Tower Research Capital (TRC)
DRTS icon

Tower Research Capital (TRC)’s Alpha Tau Medical DRTS Stock Holding History

Tower Research Capital (TRC)’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,269
Closed -$37K – 5972
2022
Q3 		$37K Buy
+6,269
New +$55.3K ﹤0.01% 3421
2022
Q2 		– Sell
-3,020
Closed -$36K – 6154
2022
Q1 		$36K Buy
+3,020
New +$35.5K ﹤0.01% 2979

Other funds holding DRTS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Summit Trail Advisors
Summit Trail Advisors New York $7.95B AUM 26.49% 1-Year Est. Return
Financial Guidance Group
Financial Guidance Group Palm Harbor, Florida $279M AUM 14.19% 1-Year Est. Return
Opal Wealth Advisors
Opal Wealth Advisors Jericho, New York $479M AUM 15.43% 1-Year Est. Return
Tower View Wealth Management
Tower View Wealth Management Shorewood, Wisconsin $231M AUM 32.95% 1-Year Est. Return

Tower Research Capital (TRC)'s DRTS Position: Q4 2022 in Review

Tower Research Capital (TRC) sold out of Alpha Tau Medical (DRTS) in Q4 2022, closing a stake of 6,269 shares — an estimated $37K sold.

Tower Research Capital (TRC) first reported a position in DRTS in Q1 2022 and held it in 2 quarters. The position peaked at $37K in Q3 2022. 14 funds tracked by Wall St. Rank hold DRTS as of Q4 2022.

  • Tower Research Capital (TRC) reported no remaining Alpha Tau Medical position as of Q4 2022 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 6,269 Alpha Tau Medical shares in Q4 2022, an estimated $37K.
  • Tower Research Capital (TRC) first reported a position in Alpha Tau Medical in Q1 2022 and held it in 2 quarters.
  • Tower Research Capital (TRC)'s Alpha Tau Medical position peaked at $37K in Q3 2022.
  • 14 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q4 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.